Biotinylated Cynomolgus PADI4 Protein (Primary Amine Labeling)
Beta LifeScience
SKU/CAT #: BLK-01126P-100UG

Biotinylated Cynomolgus PADI4 (Primary Amine Labeling) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Cynomolgus PADI4 Protein (Primary Amine Labeling)
Beta LifeScience
SKU/CAT #: BLK-01126P-100UG
Collections: High-quality recombinant proteins, Other recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Cynomolgus PADI4 Protein (Primary Amine Labeling) is expressed from E.coli with His tag at the N-Terminus.It contains Met1-Pro663. |
Purity | > 95% as determined by Tris-Bis PAGE |
Accession | A0A2K5USI5 |
Target Symbol | PADI4 |
Species | Cynomolgus |
Expression System | E. coli |
Tag | N-His |
Expression Range | Met1-Pro663 |
Mol. Weight | The protein has a predicted MW of 76.6 kDa same as Tris-Bis PAGE result. |
Form | Liquid |
Formulation | Supplied as 0.22um filtered solution in 20mM Tris, 500mM NaCl, 10% Glycerol, 0.5mM TCEP, 1mM EDTA (pH 8.0). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | Peptidylarginine deiminase type4 (PADI4) was firstly identified as a non-MHC RA genetic risk factor. Furthermore, PADI4 risk allele possessed the association with bone damage regardless of anti citrullinated peptide antibody (ACPA) positivity in Asian RA patients. PADI4 gene codes PAD4 protein which has post-translational modification activity (citrullination). Padi4 is mainly expressed in myeloid cells and granulocytes. |